Cargando…
Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors
The blood-brain barrier (BBB) poses a major obstacle by preventing potential therapeutic agents from reaching their intended brain targets at sufficient concentrations. While transient disruption of the BBB has been used to enhance chemotherapeutic efficacy in treating brain tumors, limitations in t...
Autores principales: | Sajesh, Babu V., On, Ngoc H., Omar, Refaat, Alrushaid, Samaa, Kopec, Brian M., Wang, Wei-Guang, Sun, Han-Dong, Lillico, Ryan, Lakowski, Ted M., Siahaan, Teruna J., Davies, Neal M., Puno, Pema-Tenzin, Vanan, Magimairajan Issai, Miller, Donald W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781504/ https://www.ncbi.nlm.nih.gov/pubmed/31533285 http://dx.doi.org/10.3390/pharmaceutics11090481 |
Ejemplares similares
-
Spermidine/Spermine N1-Acetyltransferase 1 (SAT1)—A Potential Gene Target for Selective Sensitization of Glioblastoma Cells Using an Ionizable Lipid Nanoparticle to Deliver siRNA
por: Yathindranath, Vinith, et al.
Publicado: (2022) -
SONIC HEDGEHOG (SHH) PROMOTES BLOOD-BRAIN BARRIER (BBB) INTEGRITY IN DIFFUSE MIDLINE GLIOMA OF THE PONS
por: Line, Stacey, et al.
Publicado: (2023) -
Modulation of Blood–Brain Barrier Permeability
in Mice Using Synthetic E-Cadherin Peptide
por: On, Ngoc H., et al.
Publicado: (2014) -
DIPG in Children – What Can We Learn from the Past?
por: Vanan, Magimairajan Issai, et al.
Publicado: (2015) -
Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides
por: Ulapane, Kavisha R., et al.
Publicado: (2019)